
The Price of an Orgasm: What Are Women Willing to Risk?
How far would you go to experience an orgasm? Would you try medication, undergo surgery, or risk your health if someone promised it could help?
For women who have never experienced orgasm, or who have lost the ability to orgasm, finding answers can become a long and frustrating journey.
Some spend years trying different techniques, consulting healthcare professionals, and searching for treatments. Others consider invasive procedures advertised as ways to improve sexual pleasure.
But what happens when the desire to orgasm becomes so powerful that women are willing to risk their health?
And why are women being offered procedures that permanently alter their bodies when we still have so much to learn about how orgasm works?
These questions reveal a troubling gap between what women are promised and what scientific research actually supports.
Orgasm, Inc.: When the Search for Orgasm Becomes Dangerous
In 2009, filmmaker Liz Canner released Orgasm, Inc., a documentary examining the pharmaceutical industry’s efforts to develop treatments for female sexual dysfunction.
The film follows a clinical trial for a proposed female equivalent of Viagra while questioning how female sexual difficulties were defined, medicalized, and marketed.
One particularly disturbing story involves a woman who underwent surgery on her clitoral hood, hoping it would help her experience orgasm during penetration.
According to the account described in the film, part of her clitoral hood was removed. She experienced severe blood loss, nearly died, and ultimately did not achieve the improvement she had hoped for.
A physician in the documentary described this type of surgery as “the acceptable form of female genital mutilation.”
The comparison is provocative, but it raises an important question.
How does removing healthy genital tissue become an acceptable medical intervention when it is marketed as a way to improve sexual pleasure?
Women should have autonomy over their bodies and the ability to make informed medical decisions. However, informed consent requires more than understanding what a procedure involves.
It also requires knowing whether the promised benefits are supported by evidence.
When a woman has spent years struggling to orgasm, even a treatment with limited scientific support may begin to look like an answer.
Can Genital Cosmetic Surgery Really Improve Orgasm?
Procedures such as labiaplasty, clitoral hood reduction, and other forms of genital cosmetic surgery are advertised for various reasons, sometimes including claims of improved sexual satisfaction or orgasm.
Some women seek these procedures because of physical discomfort. Others have concerns about appearance or hope to improve their sexual experiences.
These motivations are different, and medically indicated procedures should not be confused with elective cosmetic surgery.
When surgery is promoted as a treatment for female orgasm difficulty, however, we need to ask:
Does scientific research actually show that these procedures help women orgasm?
What Does the FDA Say About Vaginal Rejuvenation?
In July 2018, the U.S. Food and Drug Administration warned about energy-based devices, including certain lasers and radiofrequency devices, being marketed for procedures described as vaginal rejuvenation.
Some were promoted as ways to improve sexual function, despite lacking FDA clearance or approval for those purposes.
The FDA identified potential complications, including burns, scarring, pain during intercourse, and chronic pain.
These energy-based treatments are different from surgical procedures such as labiaplasty and clitoral hood reduction. Both categories, however, raise questions about evidence, safety, and marketing claims.
The American College of Obstetricians and Gynecologists (ACOG, 2020) has also raised concerns about elective female genital cosmetic procedures, emphasizing that claims of improved sexual function are not supported by adequate high-quality evidence.
These warnings matter because genital procedures can permanently alter tissue, sensation, and anatomy.
A treatment should not be considered effective simply because it is available or marketed as sexual enhancement.
What Does Labiaplasty Research Show?
A 2025 systematic review by Aulia et al., published in Plastic and Reconstructive Surgery Global Open, examined 16 studies involving 1,143 women who underwent labiaplasty.
Women reported various reasons for seeking surgery, including physical discomfort, appearance concerns, psychological factors, and sexual dissatisfaction.
Some studies reported improvements in comfort, confidence, or overall satisfaction.
However, most changes in sexual function were not statistically significant, and the review did not establish that labiaplasty improves orgasm.
This distinction is important.
A woman may feel more comfortable with her genital appearance after surgery without experiencing any improvement in her ability to orgasm.
Sexual confidence, satisfaction, and orgasmic function are related aspects of sexual experience, but they are not interchangeable.
What About Clitoral Hood Reduction?
Clitoral hood reduction involves surgically removing or reshaping tissue surrounding the clitoral glans.
It is sometimes advertised as a way to increase clitoral exposure and improve sexual sensation.
Yet the research supporting these claims remains limited.
Published studies are often small, conducted by the surgeons performing the procedures, and focused primarily on satisfaction with appearance rather than measurable changes in orgasm.
This makes it difficult to determine whether the procedure improves orgasm, which women might benefit, and what long-term complications may occur.
The clitoris is a highly innervated structure. Procedures involving surrounding tissue carry potential risks, including scarring, pain, altered sensation, and dissatisfaction.
These risks deserve careful consideration when the intended outcome is improved orgasm.
They also lead to a question that challenges the assumption behind some surgical approaches:
If orgasm depends partly on the state the nervous system is in, why would cutting tissue necessarily help a woman access that state?
Anatomical conditions can contribute to sexual difficulties, and surgery may be appropriate for certain medical problems.
But changing anatomy is not the same as addressing the neurological processes involved in orgasm.
Female Genital Mutilation: What Does Research Tell Us?
The discussion becomes more complicated when we examine female genital mutilation, or FGM.
According to the World Health Organization (WHO), FGM involves procedures that remove or injure female genital tissue for non-medical reasons.
It has no health benefits and can cause serious physical and psychological harm.
UNICEF (2024) reported that more than 230 million girls and women alive worldwide had undergone FGM.
The estimates included approximately 144 million in Africa, 80 million in Asia, and 6 million in the Middle East.
FGM occurs in communities across several regions, particularly in parts of Africa. It is internationally recognized as a violation of human rights.
Elective genital cosmetic surgery and FGM are not identical. Consent, medical circumstances, motivations, and social pressures can differ substantially.
Still, the comparison raised in Orgasm, Inc. encourages us to examine how genital tissue removal is justified in different settings.
In one context, genital cutting may be imposed through cultural expectations. In another, removing or reshaping tissue may be marketed as a way to improve sexual pleasure.
The circumstances differ, but claims about benefits and risks still require scientific scrutiny.
How Does FGM Affect Sexual Function?
A 2020 systematic review and meta-analysis published in the European Journal of Obstetrics & Gynecology and Reproductive Biology examined sexual functioning among women who had undergone FGM.
The analysis included 15 studies involving 6,672 women.
Researchers found that women who had undergone FGM generally reported lower sexual function than women who had not.
Among the sexual function domains examined, orgasm showed the largest difference.
These findings highlight the potential consequences of genital injury for sexual health.
However, they do not mean that women who have undergone FGM cannot experience orgasm. Sexual functioning varies considerably, and the effects depend on multiple factors.
The findings also cannot predict the outcome of every type of genital surgery.
What they demonstrate is that altering genital tissue can have significant consequences.
When a procedure is offered as a way to improve orgasm, its benefits must be supported by evidence strong enough to justify the risks.
Why Are There So Few Treatments for Female Orgasm Difficulty?
One reason women may become vulnerable to questionable treatments is the lack of a clear, consistently available medical treatment pathway for female orgasmic disorder.
Consider how erectile dysfunction is treated.
Men have access to multiple FDA-approved medications, established clinical guidelines, and a recognized medical specialty, urology, that routinely evaluates and treats the condition.
Women experiencing orgasm difficulty face a different situation.
There is currently no FDA-approved medication specifically for female orgasmic disorder.
Two medications, Addyi (flibanserin) and Vyleesi (bremelanotide), have been approved for certain forms of low sexual desire in premenopausal women.
But these medications treat hypoactive sexual desire disorder, not orgasmic disorder.
A woman may experience sexual desire, become physically aroused, and enjoy stimulation while remaining unable to orgasm.
Increasing desire does not necessarily address what prevents orgasm from occurring.
The Treatment Gap Between Men and Women
A 2024 study published in the Journal of General Internal Medicine examined differences in the diagnosis and treatment of sexual dysfunction.
The study included 16,591 men diagnosed with erectile dysfunction and 6,540 women diagnosed with sexual dysfunction.
Researchers found that 41% of men received treatment, compared with 33% of women.
When primary care providers made the diagnosis, men were more likely to receive treatment, while women were less likely.
The study examined female sexual dysfunction broadly, not orgasm difficulty alone. Nevertheless, it illustrates an important gap in sexual healthcare.
Women may be less likely to receive consistent evaluation and treatment for sexual concerns.
For someone experiencing persistent orgasm difficulty, this can mean years of uncertainty.
She may consult gynecologists, primary care physicians, therapists, and sexual medicine specialists without finding an explanation or an effective treatment.
Searching for Answers Like Patients With Rare Diseases
Women with orgasm difficulty can sometimes experience a treatment journey resembling that of patients with rare or poorly understood conditions.
They move from one healthcare provider to another, hoping to find someone who understands their symptoms.
This does not mean female orgasm difficulty is rare.
Rather, limited treatment options, fragmented care, and uncertainty can make finding help unusually difficult.
Clinical guidance exists, including the standard operating procedures for female orgasmic disorder described by Laan et al. (2013), but there is no universally effective intervention.
When established treatments do not provide answers, women may become more vulnerable to expensive or inadequately supported procedures.
A treatment advertised as a breakthrough can sound promising when everything else has failed.
But the absence of an effective treatment does not make an unproven treatment effective.
Women deserve better options, not greater risks.
Orgasmic Learning: What If We Are Asking the Wrong Question?
Much of the conventional discussion surrounding female orgasm difficulty focuses on sexual stimulation.
Women may be encouraged to try different techniques, use vibrators, increase clitoral stimulation, or address psychological and relationship concerns.
These approaches can be helpful, and some have established roles in clinical care.
But they may not fully explain why a woman can experience strong sexual arousal and still be unable to orgasm.
What if orgasm depends on more than the amount or type of stimulation?
What if it also depends on whether the nervous system can enter the conditions that make orgasm possible?
This is the question behind Orgasmic Learning.
Understanding Orgasm as a Learned Response
In my 2026 paper, Orgasmic Learning as a Treatment Framework for Female Orgasmic Disorder/Difficulty: A Review Using Perelman’s Sexual Tipping Point® Model, published in Current Sexual Health Reports, I proposed a framework for understanding orgasmic accessibility through learning and changes in nervous system state.
The framework draws on decades of research examining female orgasm, including studies involving physical stimulation, mental imagery, hypnosis, pelvic floor activity, cannabis, and altered states of consciousness.
Together, these research areas raise the possibility that orgasm may become more accessible when the nervous system enters certain conditions that support orgasmic response.
These conditions may involve changes in attention, sensory processing, emotional regulation, sexual excitation, and inhibition.
In other words, orgasm may depend not only on what happens to the genitals, but also on what happens throughout the nervous system.
Think about learning to ride a bicycle.
At first, balancing, steering, and coordinating movement require conscious effort.
With practice, these responses become more familiar and increasingly automatic.
The nervous system learns to coordinate a complex activity.
Orgasmic Learning proposes that certain aspects of orgasmic accessibility may develop through a similar learning process.
A woman may begin by discovering the conditions under which orgasm becomes possible.
Repeated experiences may help strengthen that response, making orgasm more reliable over time.
Eventually, the response may become accessible in different circumstances or through different forms of stimulation.
This is a proposed treatment framework, not a guarantee that every woman can resolve orgasm difficulty through practice.
Further clinical research is needed to establish its effectiveness.
But it changes the question from what needs to be fixed in a woman’s body to what conditions may help her nervous system access orgasm.
Why Safety and Nervous System State Matter
One important part of Orgasmic Learning is understanding the relationship between sexual excitation and inhibition.
Sexual excitation involves processes that support sexual responsiveness.
Sexual inhibition involves processes that interfere with or reduce that response.
Anxiety, fear, pain, distraction, and persistent self-monitoring may increase inhibition.
Pleasurable stimulation, erotic attention, and certain absorbed states may support sexual responsiveness.
A woman can experience substantial physical stimulation while remaining in a state of heightened monitoring or inhibition.
Increasing stimulation alone may not resolve that difficulty.
This is why understanding nervous system state may be important.
The question becomes whether a woman can learn to access conditions that support orgasm rather than repeatedly trying to overcome difficulty through greater stimulation.
What if the question isn’t what’s wrong with your body, but what state your body needs to be in?
That question may lead us toward a different understanding of female orgasm difficulty.
Women Deserve Better Answers, Not Greater Risks
The story in Orgasm, Inc. illustrates the consequences of searching for orgasm in a medical environment where clear answers are often difficult to find.
A woman underwent an invasive procedure hoping to experience something she had been unable to achieve.
The procedure carried serious consequences and did not provide the outcome she wanted.
Her experience raises questions about the treatments women are offered and whether those treatments are supported by scientific evidence.
Research on genital cosmetic surgery, female genital mutilation, and treatment disparities shows why these questions matter.
Women’s sexual health deserves rigorous scientific investigation, meaningful treatment options, and clear information about risks and benefits.
Orgasmic Learning offers another direction for research by examining the conditions under which orgasm becomes accessible and whether those conditions can be developed through learning.
The framework is still evolving, but it challenges the assumption that persistent orgasm difficulty must always be addressed by changing the body.
How much should a woman have to risk to experience an orgasm, and what if the answer begins with understanding how her nervous system learns?
Learn more about Orgasmic Learning and explore the research behind this emerging framework.
References
American College of Obstetricians and Gynecologists. (2020). Elective female genital cosmetic surgery (Committee Opinion No. 795). https://www.acog.org/clinical/clinical-guidance/committee-opinion/articles/2020/01/elective-female-genital-cosmetic-surgery
Aulia, I., et al. (2025). Behind the decision: Exploring motivations, and psychological and sexual outcomes of labiaplasty. Plastic and Reconstructive Surgery Global Open. https://doaj.org/article/4ee45e90d61b451fa62f777246e30b7c
Canner, L. (Director). (2009). Orgasm, Inc. [Documentary film]. https://en.wikipedia.org/wiki/Orgasm_Inc.
Female genital mutilation and sexual function: Systematic review and meta-analysis. (2020). European Journal of Obstetrics & Gynecology and Reproductive Biology. https://zaguan.unizar.es/record/149853?ln=en
Gap in sexual dysfunction management between male and female patients seen in primary care. (2024). Journal of General Internal Medicine. https://pesquisa.bvsalud.org/portal/resource/pt/mdl-39231849
Laan, E., Rellini, A. H., & Barnes, T. (2013). Standard operating procedures for female orgasmic disorder. The Journal of Sexual Medicine. https://doi.org/10.1111/j.1743-6109.2012.02880.x
Mulvehill, S. (2026). Orgasmic learning as a treatment framework for female orgasmic disorder/difficulty: A review using Perelman’s Sexual Tipping Point® Model. Current Sexual Health Reports, 18, Article 16. https://doi.org/10.1007/s11930-026-00428-w
Mulvehill, S., & Tishler, J. (2025). Cannabis for female orgasmic disorder/difficulty: A systematic review. Sexual Medicine. https://doi.org/10.1093/sexmed/qfaf061
UNICEF. (2024). Female genital mutilation: A global concern. https://data.unicef.org/resources/female-genital-mutilation-a-global-concern-2024/
U.S. Food and Drug Administration. (2018). FDA warning concerning energy-based devices marketed for vaginal rejuvenation. https://www.fda.gov/news-events/press-announcements/statement-fda-commissioner-scott-gottlieb-md-efforts-safeguard-womens-health-deceptive-health-claims
World Health Organization. (n.d.). Female genital mutilation. https://www.who.int/health-topics/female-genital-mutilation
Medical disclaimer: This article is intended for educational purposes only and does not provide medical advice or recommend any surgical, pharmaceutical, or other treatment. Women experiencing persistent orgasm difficulty or other sexual health concerns should consult an appropriately qualified, licensed healthcare professional.



